Cardioprotective effects of novel NLRP3 inflammasome inhibitors

被引：0

作者：

Comita, Stefano ^{[1
]}

Pagliaro, Pasquale ^{[1
]}

Penna, Claudia ^{[1
,2
]}

Bertinaria, Massimo ^{[3
]}

Spyrakis, Francesca ^{[3
]}

Gastaldi, Simone ^{[3
]}

Boscaro, Valentina ^{[3
]}

Gianquinto, Eleonora ^{[3
]}

机构：

[1] Univ Turin, Dept Clin & Biol Sci, Turin, Italy

[2] Nat Inst Cardiovasc Res, Bologna, Italy

[3] Univ Turin, Dept Drug Sci & Technol, Turin, Italy

来源：

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY | 2022年 / 173卷

关键词：

D O I：

10.1016/j.yjmcc.2022.08.241

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P289

引用

页码：S123 / S124

页数：2

共 50 条

[21] Design, synthesis and biological evaluation of novel diphenylamine analogues as NLRP3 inflammasome inhibitors
Kang, Tongtong
Sun, Simin
Wang, Huimin
Liu, Jinyu
Li, Xiaoyang
Jiang, Yuqi
BIOORGANIC & MEDICINAL CHEMISTRY, 2024, 113
[22] Novel Macrocyclic NLRP3 Inhibitors
Mesch, Stefanie
Shannon, Jonathan
Miller, David
Macleod, Angus
Bouche, Lea
Johnston, Heather J.
Matthews, Kim
Paehler, Axel
Best, Stuart
Guba, Wolfgang
Alanine, Thomas
Halai, Reena
Charge, Lorna
Garside, Samantha
Thom, Stephen
Incerti-Pradillos, Celia
Mcpherson, Christopher
Carrillo, Jokin
St-Gallay, Steve
Rigo, Pierre
Schlicht, Sonja
Hendrick, Alan G.
Lerner, Christian
Piali, Luca
Blaising, Julie
Mracsko, Eva Z.
Jaeschke, Georg
Cooper, Matthew A.
JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (23) : 20911 - 20932
[23] Discovery of Novel NLRP3 Inflammasome Inhibitors Composed of an Oxazole Scaffold Bearing an Acylsulfamide
Ohba, Yusuke
Adachi, Kaoru
Furukawa, Takayuki
Nishimaru, Tatsuya
Sakurai, Kentaro
Masuo, Ritsuki
Inami, Tasuku
Orita, Takuya
Akai, Shota
Adachi, Tsuyoshi
Usui, Kenji
Hamada, Yuji
Mori, Mutsuki
Kurimoto, Takafumi
Wakashima, Takeshi
Akiyama, Yoshiyuki
Miyazaki, Susumu
Noji, Satoru
ACS MEDICINAL CHEMISTRY LETTERS, 2023, 14 (12): : 1833 - 1838
[24] Identification and Characterization of Novel NLRP3 Inflammasome Inhibitors for the Potential Treatment of Retinal Disease
Rodriguez, Mirna
Meng, Frank
Bishop, Michael
Perlroth, D. Victor
Liang, Hong
Jandeleit, Bernd
Williams, Kim
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
[25] Novel Aryl Sulfonamide Derivatives as NLRP3 Inflammasome Inhibitors for the Potential Treatment of Cancer
Albanese, Valentina
Missiroli, Sonia
Perrone, Mariasole
Fabbri, Martina
Boncompagni, Caterina
Pacifico, Salvatore
De Ventura, Tiziano
Ciancetta, Antonella
Dondio, Giulio
Kricek, Franz
Pinton, Paolo
Guerrini, Remo
Preti, Delia
Giorgi, Carlotta
JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (07) : 5223 - 5241
[26] NLRP3 Inflammasome: a Novel Insight into Heart Failure
Wang, Yunjiao
Li, Yanyang
Zhang, Wanqin
Yuan, Zhuo
Lv, Shichao
Zhang, Junping
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2023, 16 (01) : 166 - 176
[27] Phytochemical inhibitors of the NLRP3 inflammasome for the treatment of inflammatory diseases
Ozenver, Nadire
Efferth, Thomas
PHARMACOLOGICAL RESEARCH, 2021, 170
[28] Promise of the NLRP3 Inflammasome Inhibitors in In Vivo Disease Models
Das, Biswadeep
Sarkar, Chayna
Rawat, Vikram Singh
Kalita, Deepjyoti
Deka, Sangeeta
Agnihotri, Akash
MOLECULES, 2021, 26 (16):
[29] Design, Synthesis and Evaluation of Oxazaborine Inhibitors of the NLRP3 Inflammasome
Baldwin, Alex G.
Tapia, Victor S.
Swanton, Tessa
White, Claire S.
Beswick, James A.
Brough, David
Freeman, Sally
CHEMMEDCHEM, 2018, 13 (04) : 312 - 320
[30] Inhibition of the NLRP3 inflammasome by HSP90 inhibitors
Nizami, Sohaib
Arunasalam, Kanisa
Green, Jack
Cook, James
Lawrence, Catherine B.
Zarganes-Tzitzikas, Tryfon
Davis, John B.
Di Daniel, Elena
Brough, David
IMMUNOLOGY, 2021, 162 (01) : 84 - 91

← 1 2 3 4 5 →